Chemistry and Physics of Lipids, Journal Year: 2024, Volume and Issue: unknown, P. 105462 - 105462
Published: Nov. 1, 2024
Language: Английский
Chemistry and Physics of Lipids, Journal Year: 2024, Volume and Issue: unknown, P. 105462 - 105462
Published: Nov. 1, 2024
Language: Английский
European Journal of Pharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 177323 - 177323
Published: Jan. 1, 2025
Language: Английский
Citations
0Nano Trends, Journal Year: 2025, Volume and Issue: unknown, P. 100092 - 100092
Published: Feb. 1, 2025
Language: Английский
Citations
0Frontiers in Medicine, Journal Year: 2025, Volume and Issue: 12
Published: March 19, 2025
The human eye is a highly intricate sensory organ. When condition requiring treatment occurs, eyedrops, which represent 90% of all ophthalmic treatments, are most frequently used. However, eyedrops associated with low bioavailability, less than 0.02% therapeutic molecules reaching the anterior chamber. Thus, new delivery systems required to ensure sufficient drug concentration over time at target site. Gold nanoparticles promising avenue for delivery; however, they can be difficult track in biological systems. Fluorescent gold nanoparticles, have same ultrastability and biocompatibility as their nonfluorescent counterpart, could act an effective imaging tool study localization throughout after administration. this (1) synthesized characterized fluorescent (2) validated similar properties between (3) determined topical application on ex vivo rabbit eyes. were synthesized, characterized, identified cornea, iris, lens, posterior segment eyeballs, demonstrating tremendous potential future research.
Language: Английский
Citations
0International Ophthalmology, Journal Year: 2025, Volume and Issue: 45(1)
Published: March 22, 2025
Language: Английский
Citations
0Nano Today, Journal Year: 2025, Volume and Issue: 63, P. 102740 - 102740
Published: April 4, 2025
Language: Английский
Citations
0Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(4), P. 523 - 523
Published: April 16, 2025
Background/Objectives: Indomethacin (IND) is a widely used non-steroidal anti-inflammatory drug (NSAID) effective in managing pain and inflammation. However, its therapeutic use often limited by gastrointestinal irritation low bioavailability. This study aimed to evaluate the biocompatibility, release kinetics, analgesic potential of IND-loaded chitosan (CHIT)-stabilized lipid vesicles (IND-ves) comparison free IND, focusing on their vivo effects impact somatic nociceptive reactivity mice. Methods: IND-ves were prepared using molecular droplet self-assembly technique, followed CHIT coating enhance stability control release. Mice administered either IND or IND-ves, various physiological parameters, including liver kidney function, oxidative stress markers, immune cell activity, histopathological changes key organs, assessed. Plasma kinetics evaluated tail-flick test. Results: Both demonstrated good with no significant hematological, biochemical, immunological profiles. exhibited sustained profile, initiating at 30 min peaking 3 h, while displayed rapid gastric mucosal damage. did not induce inflammation maintained organ integrity, particularly protecting against injury. Additionally, prolonged profile contributed extended Conclusions: CHIT-stabilized offer promising delivery system for enhancing release, prolonging efficacy, minimizing irritation. These findings suggest that could serve as safer more alternative NSAID therapy.
Language: Английский
Citations
0International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: unknown, P. 139017 - 139017
Published: Dec. 1, 2024
Language: Английский
Citations
1Chemistry and Physics of Lipids, Journal Year: 2024, Volume and Issue: unknown, P. 105462 - 105462
Published: Nov. 1, 2024
Language: Английский
Citations
0